Royal Philips has announced the integration of its Interventional Hemodynamic system and portable patient monitor IntelliVue X3, providing advanced haemodynamic measurements at the tableside in the cath lab and continuous monitoring of key vital signs throughout the patient journey.
In a press release, Philips says that the integration provides the opportunity for monitoring during image-guided procedures on its image-guided therapy system—Azurion—to improve workflow with comprehensive patient records that support timely clinical decision-making during interventional cardiology procedures. The solution will be introduced at the American College of Cardiology’s 70th Annual Scientific Session (ACC.21, 15–17 May, virtual).
“Philips Interventional Hemodynamic System with Patient Monitor IntelliVue X3 is a unique combination made possible by our strengths in patient monitoring and image-guided therapy,” said Ronald Tabaksblat, general manager image guided therapy systems at Philips. “Bringing advanced haemodynamic measurements to the tableside as an integrated part of our Azurion image-guided therapy system, it helps allow clinicians to assess the condition of the patient in real time during an intervention, without leaving the sterile field. It also streamlines workflows, providing continuous monitoring of the patient during every step of their care path, enhancing patient safety and confidence.”
The IntelliVue X3 patient monitor can be connected to the patient from anywhere in the hospital, after which it stays with them throughout the interventional procedure, providing continuous monitoring and registration of their vital signs in the IntelliVue IT solution.
After connecting the IntelliVue X3 to its docking station at the tableside of the Azurion system, clinical staff can monitor all of the patient’s vital signs including pulse oximetry end-tidal CO2, perform haemodynamic analyses and 12-lead ECG acquisitions, and relay results and waveforms from the lab’s control room to the Azurion tableside display. From the tableside the interventionalists can assess the data using the Azurion tableside Touch Screen Module, allowing them to remain focused on their patients. The system brings the latest physiological techniques to the interventional lab, including iFR (instant wave-Free Ratio) measurements, a hyperaemia-free technique unique to Philips that provides valuable functional information regarding the severity of lesions in the coronary arteries.
